M
Mereo BioPharma Group plc (MREO)
NCM – Real vaqt narxi. Valyuta: USD
0.30
-0.00 (-1.46%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.30
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.30
-0.00 (-1.46%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.30
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 6.48 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 6.48 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | 10M | N/A | 501K | 506K |
| Yalpi foyda | 257K | 6M | -1M | -784K | -825K |
| Operatsion daromad | -54M | -29M | -47M | -41M | -38M |
| Sof foyda | -42M | -30M | -43M | -42M | -36M |
| EBITDA | -53M | -27M | -46M | -39M | -37M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 366.67 | 29.7 | 10 |
| Keyingi chorak | -100 | -56.2 | 1.0 |
| Joriy yil | 2755 | 76.67 | 10 |
| Keyingi yil | 90.01 | 32.68 | 10 |
| O‘rtacha ball | 7.8 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 8.62 | 0 | 43.88 | 6.8 |
| Yil/Yil | 999 | 48.15 | 50 | 48.64 | 10 |
| 3 yil o‘rtacha | 632.67 | -4.49 | 4.18 | 1.81 | 4.5 |
| 5 yil o‘rtacha | 559.4 | -49.16 | 19.67 | -81.19 | 5.3 |
| O‘rtacha ball | 6.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Naqd pul zahiralari $36.2M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $40.0M jami joriy majburiyatlardan $6.2M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$4.3M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi